Davide T.
- Country
- Italy
- Department
- UO Oncologia
Research Overview
- Phase 2 Study of Chemoimmunotherapy with Pembrolizumab and Olaparib Maintenance in Extensive-Stage Small-Cell Lung Cancer
- Phase III Randomized Trial of Short vs. Long-Course Preoperative Chemotherapy with mFOLFIRINOX or PAXG in Stage I-III Pancreatic Ductal Adenocarcinoma
- Phase 3 Randomized Open-Label Trial of OSE2101 Versus Docetaxel in HLA-A2 Positive Metastatic NSCLC Patients with Secondary Resistance to Immune Checkpoint Inhibitors
Data & Insights
Has run more than one trial at 19 of 193 partner sites.
Specializations
Lung Cancer Research
This investigator specializes in various forms of lung cancer treatment, with particular focus on non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Their research encompasses innovative therapeutic approaches including immunotherapy and targeted treatments.
- MET Deregulation Studies
- Therapeutic Cancer Vaccines
- Extensive-Stage SCLC Treatment
The investigator explores combination therapies including chemo-immunotherapy and maintenance treatments.
Prostate Cancer Studies
The investigator conducts research in high-risk nonmetastatic prostate cancer treatment, focusing on hormone therapy combinations and therapeutic interventions for disease progression after initial treatment.
- Hormone Therapy Evaluation
- Post-Definitive Therapy Progression
- Combined Treatment Approaches
Their work examines various therapeutic combinations to improve treatment outcomes in prostate cancer patients.
Pancreatic Cancer Research
The investigator's work includes studies in pancreatic ductal adenocarcinoma (PDAC), with particular attention to pre-operative treatment strategies and chemotherapy protocols.
- Pre-operative Chemotherapy Optimization
- Treatment Duration Studies
- Comparative Treatment Efficacy
Research focuses on determining optimal treatment durations and comparing different chemotherapy regimens.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.